[Use of rituximab in maintenance treatment of pemphigus: A retrospective series].

CONCLUSION: This survey of the practical use of RTX confirms its interest in moderate to severe pemphigus as a second-line or subsequent treatment, a situation that probably remains relevant even if this molecule is increasingly used as first-line therapy.
PMID: 31955970 [PubMed - as supplied by publisher]

Source: Annales de Dermatologie et de Cenereologie - January 15, 2020 Category: Dermatology Authors: Barroil M, Girard C, Lerisson M, Negroni V, Bertrand AS, Pallure V, Bessis D, Guillot B, Dereure O Tags: Ann Dermatol Venereol Source Type: research